FPS
OGN icon

Fieldpoint Private Securities’s Organon & Co OGN Stock Holding History

Fieldpoint Private Securities’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$7K Sell
215
-287
-57% -$10.1K ﹤0.01% 832
2022
Q1 		$18K Buy
502
+80
+19% +$2.74K ﹤0.01% 878
2021
Q4 		$13K Buy
422
+67
+19% +$2.18K ﹤0.01% 1012
2021
Q3 		$12K Buy
355
+20
+6% +$640 ﹤0.01% 992
2021
Q2 		$10K Buy
+335
New +$11K ﹤0.01% 1025

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fieldpoint Private Securities's OGN Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Organon & Co (OGN) stake by 57% in Q2 2022, selling an estimated $10.1K and leaving 215 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #832.

Fieldpoint Private Securities first reported a position in OGN in Q2 2021 and has held it in 5 quarters since. The position peaked at $18K in Q1 2022. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Fieldpoint Private Securities held 215 shares of Organon & Co worth $7K as of Q2 2022.
  • Fieldpoint Private Securities sold 287 Organon & Co shares in Q2 2022, an estimated $10.1K.
  • Organon & Co made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #832 holding.
  • Fieldpoint Private Securities first reported a position in Organon & Co in Q2 2021 and has held it in 5 quarters since.
  • Fieldpoint Private Securities's Organon & Co position peaked at $18K in Q1 2022.
  • 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.